Worked with finance and tax team on a cross-border transaction structure to give a growing life sciences company the ability to migrate IP at a later date if a global expansion were successful. The economic modeling included the valuation of an option on specified rights to the IP portfolio and considered financial, cash, and tax consequences of a range of business scenarios in support of executive decision making.
CRA consultants named top IP strategists in IAM Strategy 300 2021
Robert Goldman, Daniel McGavock, Dr. Richard Razgaitis, and Larry Rosenberg were recognized in the latest edition of IAM Strategy 300 – The World’s Leading IP...